Netherlands – Vaccines – Afmelding DKT-vaccins - RIVM & GSK
Rijksinstituut voor Volksgezondheid en Milieu (RIVM) awarded €4.8M to GlaxoSmithKline B.V. for Construction & Public Works in March 2025 — one of 8 awards this buyer has made, above its typical award size.
Buying agency
Rijksinstituut voor Volksgezondheid en Milieu (RIVM)Winning supplier
GlaxoSmithKline B.V.Contract description
Netherlands – Vaccines – Afmelding DKT-vaccins - RIVM & GSK
Related awards · Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
8 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-186082-2025Pfizer B.V.€143K24 Mar 2025 Construction
- ocds-ted-686007-2025-3MLS nv€128K17 Oct 2025 Construction
- ocds-ted-686007-2025-1BD-medical€91.2K17 Oct 2025 Construction
Other wins · GlaxoSmithKline B.V.
8 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Rijksinstituut voor Volksgezondheid en Milieu (RIVM) and GlaxoSmithKline B.V. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back